PharmaEngine, Inc. and Guangzhou BeBetter Medicine Technology Signed a Collaboration and Research Agreement
1/3/2013 9:25:24 AM
More...
|
PharmaEngine, Inc. Nabs Rights to Nanobiotix's Nanoparticle Radiotherapy Booster for Up to $57 Million
8/6/2012 7:54:44 AM
More...
|
PharmaEngine, Inc. and Merrimack Pharmaceuticals Inc. Enter into a Licensing and Collaboration Agreement; PharmaEngine Eligible for $220 Million Upfront and Milestone Payments Plus Royalties
5/9/2011 6:57:44 AM
More...
|
PharmaEngine, Inc. Receives Approval of US IND Application for a Phase II Study of PEP02 (Liposome Irinotecan Injection) in Pancreatic Cancer
12/3/2008 9:21:16 AM
More...
|
Xenova Group PLC (XNVA) Grants Licence To PharmaEngine, Inc.
10/19/2005 5:13:16 PM
More...
|